Klonopin - drug sheet PDF

Preview

Summary

drug sheet...

Description

Bristol Community College NUR 101 Medication Sheet

Medications administered on your time Medication & Classification 1. 2. 3. 4. 5. 6.

Name of drug (trade/generic) Dosage R/A All times due All classifications Safe dose

1. Generic: ClonazePAM

Trade: Klonopin

1.Drug Action

1.

List the most common side effects/adverse reactions

2.Reason pt. is on medication. (Be specific)

2.

List all significant nursing actions related to the administration of med to this patient and number them.

1. Pharmacodynamics:

I. Most common side effects/adverse reactions

Anticonvulsant effects may be due to presynaptic inhibition. Produces sedative effects in the CNS, probably by stimulating inhibitory GABA

2. Dosage: 1mg PO BID

CNS: SUICIDAL THOUGHTS, behavioral changes, drowsiness Neuro: ataxia

II. Nursing actions:

receptors.

A. Assessment:

3. Route of Administration: PO

Therapeutic Effect(s): Prevention of

1.Assess degree and manifestations of anxiety and

seizures, decreased manifestations of

mental status (orientation, mood, behavior) prior to and periodically during therapy.

panic disorder.

4. Scheduled times: 0900, 1500

5. Classifications: benzodiazepines Therapeutic: anti-convulsant

Pharmacokinetics: Onset: 20-60minutes

2.Assess need for continued treatment regularly. 3.Assess patient for drowsiness, unsteadiness, and

Peak: 1-2 hours

clumsiness. These symptoms are dose related and most severe during initial therapy; may decrease in

Duration: 6-12 hours

severity or disappear with continued or long-term therapy.

Absorption: Well absorbed from the GI 6. Safe dose: PO (Adults): 0.5 mg 3 times

tract.

daily; may ↑ by 0.5–1 mg every 3 days. Total daily maintenance dose not to exceed 20 mg. Panic disorder– 0.125 mg twice daily; ↑ after 3 days toward target dose of 1 mg/day (some patients may require up to 4 mg/day).

Distribution: Probably crosses the blood-brain barrier and the placenta.

7. Is this medication a HIGH ALERT drug? BEERS drug Class IV controlled substance

Excretion: not listed

8. Is this medication a “Look alike/sound alike” drug? Do not confuse clonazepam with alprazolam, clonidine, clozapine, clobazam, or lorazepam. Do not confuse Klonopin with clonidine.

Metabolism: Mostly metabolized by the

4.Monitor closely for notable changes in behavior that could indicate the emergence or worsening of suicidal thoughts or behavior or depression.

Lab Test Considerations:

liver.

Geriatric considerations: This medication is a BEERS drug and is not recommended for geriatric patients May experience excessive sedation at

5.Patients on prolonged therapy should have CBC and liver function test results evaluated periodically. May cause an ↑ in serum bilirubin, AST, and ALT. 6.May cause ↓ thyroidal uptake of 123 I, and 131 I.

usual doses; ↓ dose recommended. Toxicity Overdose:

2. Reason patient is on med. Patient has anxiety and seizures, medication can treat both, but this medication seems to be for the anxiety

7.Therapeutic serum concentrations are 20–80 mg/mL.

B. Administration: 1.Do not confuse clonazepam with alprazolam,

Bristol Community College NUR 101 Medication Sheet

clonidine, clozapine, clobazam, or lorazepam. Do not confuse Klonopin with clonidine. 2.Institute seizure precautions for patients on initial therapy or undergoing dose manipulations. 3.PO Administer with food to minimize gastric irritation. Tablets may be crushed if patient has difficulty swallowing. Administer largest dose at bedtime to avoid daytime sedation. Taper by 0.25 mg every 3 days to decrease signs and symptoms of withdrawal. Some patients may require longer taper period (months).

C. Teaching: 1.Instruct patient to take medication exactly as directed. Take missed doses within 1 hr or omit; do not double doses. Abrupt withdrawal of clonazepam may cause status epilepticus, tremors, nausea, vomiting, and abdominal and muscle cramps. Instruct patient to read the Medication Guide before starting and with each Rx refill, changes may occur. 2.Advise patient that clonazepam is usually prescribed for short-term use and does not cure underlying problems. 3.Advise patient to not share medication with others. 4.May cause drowsiness or dizziness. Advise patient to avoid driving or other activities requiring alertness until response to drug is known. 5.Instruct patient to notify health care professional of all Rx or OTC medications, vitamins, or herbal products being taken and to consult health care professional before taking any other Rx, OTC, or herbal products. Caution patient to avoid taking alcohol or other CNS depressants concurrently with this medication. 6.Advise patient to notify health care professional of medication regimen prior to treatment or surgery. 7.Instruct patient and family to notify health care professional of unusual tiredness, bleeding, sore throat, fever, clay-colored stools, yellowing of skin, or behavioral changes. Advise patient and family to notify health care professional if thoughts about suicide or dying, attempts to commit suicide; new or worse depression; new or worse anxiety; feeling very agitated or restless; panic attacks; trouble sleeping; new or worse irritability; acting aggressive; being angry or violent; acting on dangerous impulses; an extreme increase in activity and talking; other unusual changes in behavior or mood occur. 8.Advise female patients to notify health care

Bristol Community College NUR 101 Medication Sheet

professional if pregnancy is planned or suspected or if breast feeding. Encourage pregnant patients to enroll in North American Antiepileptic Drug (NAAED) Pregnancy Registry to collect information about safety of antiepileptic drugs during pregnancy. To enroll, patients can call 1-888-233-2334. 9.Patient on anticonvulsant therapy should carry identification at all times describing disease process and medication regimen. 10.Emphasize the importance of follow-up exams to determine effectiveness of the medication.

(Vallerand, A. H. & Sanoski, C. A., 2020, pp.332-334, 1351-1352). Vallerand, A., & Sanoski, C. (2020). Davis's drug guide for nurses (17th ed.). F.A. Davis Company....